Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile
StockNews.AI · 3 hours
AI Summary
Compass Pathways reports COMP006 Part B 26-week results for COMP360, reinforcing rapid onset and durable relief in treatment-resistant depression across nearly 600 patients. A 39% MADRS ≥25% response at week 6 and retreatment-associated remission support a potential new standard of care, with rolling NDA submission on track for final submission in Q4 2026 and a possible 1H 2027 launch pending regulatory approval.
Sentiment Rationale
Positive Phase 3 durability and rapid-onset data across two trials, plus a rolling NDA with a clear final submission target and a defined 1H 2027 launch window, create a tangible near-term catalyst for CMPS. Historical analogs show multi-trial positive results paired with NDA milestones often yield outsized moves as FDA decisions approach.
Trading Thesis
CMPS likely to rise on NDA progress and 1H2027 launch potential within months.
Market-Moving
- Rolling NDA progress and Q4 2026 final submission provide near-term catalysts.
- 39% MADRS ≥25% response at week 6 supports a differentiated TRD profile.
- Remission after retreatment (~30% of Week-6 responders) strengthens durability thesis.
- Webcast on July 7 could influence near-term sentiment.
Key Facts
- COMP360 Part B shows 26-week durable TRD efficacy. Rapid onset persists.
- 39% achieved ≥25% MADRS at week 6 with 25 mg; durability to 26.
- Rolling NDA underway; final submission in Q4 2026; 1H 2027 launch planned.
- Launch readiness on track; PTSD program progress and July 7 webinar.
Companies Mentioned
- Compass Pathways plc (CMPS): Primary driver of the data; regulatory timeline emphasizes potential 2027 launch.
- Mindful Health Solutions (N/A): Quoted as a participant-affiliated group; no direct market impact without monetizable linkage.
Industry News
Corporate Developments within Industry News: A pivotal trial data release and NDA timeline signaling potential near-term regulatory and commercial milestones for COMP360.